Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

The Tobramycin Study

This study has been completed.
Sponsor:
Collaborators:
The National Institute of Health, Oslo
Ullevaal University Hospital
Sorlandet Hospital HF
Sykehuset Buskerud
Sentralsjukehuset i Rogaland
Sykehuset Innlandet HF
Sentralsjukehuset i Hedemark
Per Arne Standal, Sykehuset i Vestfold, Tønsberg
Sykehuset Asker og Baerum
Information provided by:
Oslo University Hospital
ClinicalTrials.gov Identifier:
NCT00257790
First received: November 22, 2005
Last updated: July 3, 2011
Last verified: November 2005
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Estimated Study Completion Date: March 2005
  Estimated Primary Completion Date: No date given